MEDITWIN (2023-2028)
Overview
Title
Precision virtual twins for healthcare
Principal investigator
Dassault Systèmes
Funding
France 2030 — programme announced in Toulouse in late 2023
Budget
€132M
Website
https://www.3ds.com/science/meditwin
Abstract
MEDITWIN is building a European, sovereign platform of digital twins for healthcare. A virtual twin is a representation of one or more physiological systems — cells, tissues and organs together fulfilling a function — generated and updated from a person’s own health data: imaging, blood work, genetic data, medical records.
The point is decision support. By combining modelling, artificial intelligence and medical knowledge, these twins aim to represent the patient’s state, predict its evolution and test the effect of candidate treatments before choosing one. They also give the various specialties following the same patient a shared representation, where coordination today rests on specialised documents.
The programme focuses on the three areas where chronic disease weighs heaviest in healthy life-years lost: cardiology, neurology and oncology, targeting prevention as much as treatment.
Partners
Fourteen partners around Dassault Systèmes.
- Seven University Hospital Institutes (IHU) — PRISM (precision oncology, Gustave Roussy), Imagine (genetic diseases), ICAN (cardiometabolism), FOReSIGHT (vision), ICM (Brain Institute), LIRYC (cardiac rhythm) and IHU Strasbourg.
- CHU de Nantes
- Inria — modelling, simulation and digital twins of organs, under the strategic partnership with Dassault Systèmes signed in 2021.
- Four startups — CODOC, inHeart, Qairnel and Neurometers.